Neonatal stem cells from the heart could treat Crohn’s disease

Research from Ann & Robert H. Lurie Children’s Hospital of Chicago found that direct injection of neonatal mesenchymal stem cells, derived from heart tissue discarded during surgery, reduces intestinal inflammation and promotes wound healing in a mouse model of Crohn’s disease-like ileitis, an illness marked by chronic intestinal inflammation and progressive tissue damage.

Power Dynamos beef up

…Salulani Phiri and Cameroonian join Zambian champions 

By MICHAEL MIYOBA

SUPER League champions Power Dynamos Football Club (PDFC) has been beefed up with the signing of five players ahead of the 2023/2024 season set to kick off on August 19, 2023.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Researchers find an epigenetic key that unlocks common deadly cancers

Early on, every stem cell faces a fateful choice. During skin development, for instance, the embryonic epidermis begins as a single layer of epidermal progenitor cells. Their choice is to become a mature epidermal cell or switch to becoming a hair follicle cell. This so-called fate switch is governed by the transcription factor SOX9. If the progenitor cell expresses SOX9, hair follicle cells develop. If it doesn’t, epidermal cells do.